As more and more people bank their childrens stem cells for their future use, the problem of finding a stem cell match could become a thing of the past, says BioEdens Group CEO Tony Veverka.
(PRWEB UK) 9 August 2014
Stem cell therapy and treatments continue to move on in finding cures for diseases that in the past were thought to be incurable. The success of stem cell treatment and therapy relies to a great extent on the ability for the patient to have a stem cell match. Although stem cell banking has been available for a number of years, the cost for many has been a barrier.
Specialist stem cell bank BioEden who operate in 21 countries have come up with a solution that brings this potentially life saving opportunity within an affordable range for the majority.
Their aim is to make stem cell therapy an affordable reality and hope that their new approach which includes a low monthly membership option will do just that.
As more and more people bank their children's stem cells for their future use, the problem of finding a stem cell match could become a thing of the past.